Document is current
Any future updates will be listed below
-
Authors
Cepni, Bahar
Batista, Vania
Hoeltgen, Line
Waldsperger, Hanna
Wessel, Lars
Liermann, Jakob
Harrabi, Semi
Weykamp, Fabian
Arians, Nathalie
Hörner-Rieber, Juliane
Debus, Jürgen
Meixner, Eva
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 9 March 2026
Accepted: 28 August 2026
First Online: 1 September 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Ethics Committee of the Medical Faculty of Heidelberg University (S535/2025) and the requirement for informed consent was waived due to the retrospective nature of the analysis. The study was performed in compliance to the Helsinki Declaration in its current version.
Consent for publication: Not applicable.
Competing interests: Outside the submitted work, JHR received speaker fees from ViewRay Inc., Pfizer Inc., Accuray Sarl, Sanofi, and Astra Zeneca, as well as travel reimbursement from Varian Medical Systems and research grants from IntraOP Medical and Varian Medical Systems. F.W. received speaker fees from AstraZeneca, Varian Medical Systems, Siemens Healthineers, Chulabhorn Royal Academy, Klinikum Darmstadt and Merck Sharp & Dohme and travel support for attending meetings from AstraZeneca, Varian Medical Systems, Novocure GmbH, German Center for Lung Research (DZL), Fraunhofer MEVIS, Chulabhorn Royal Academy and Micropos Medical as well as compensation for advisory boards from Novocure GmbH and Merck Sharp & Dohme.
